ANTXR1 and neoplasm: Antibodies blocking the TEM8/ANTXR1 extracellular domain inhibit tumor related angiogenesis and tumor growth (Opoku-Darko et al., 2007; Chaudhary et al., 2012; Gong et al., 2018; Szot et al., 2018).